/PRNewswire/ Buchanan Ingersoll & Rooney is pleased to announce that it has added former Patent Trial and Appeal Board (PTAB) Deputy Chief Judge James T..
In our PTAB Spotlight Series, attorneys will share their valuable insights on PTAB practice today, the challenges and opportunities clients face, and the trends practitioners should.
The Federal Circuit has rejected a constitutional challenge of the USPTO's practice of excluding Patent Trial and Appeal Board (PTAB) institution decisions from its director review process.
The primary legislation governing the authorisation, marketing, sale and supply of pharmaceutical products by the US Food and Drug Administration (FDA) .